Gemcitabine
In Stock•Starting at $8 for 250 mg•Purity ≥ 98%
| CAS No. | 95058-81-4 |
|---|---|
| MDL No. | MFCD00869720 |
| MF | C9H11F2N3O4 |
| MW | 263.20 |
| InChI Key | SDUQYLNIPVEERB-QPPQHZFASA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 250 mg | 98% | $8 | In Stock | |
| 1 g | 98% | $9 | In Stock | |
| 5 g | 98% | $32 | In Stock | |
| 10 g | 98% | $57 | In Stock | |
| 25 g | 98% | $130 | In Stock |
Product Information
Gemcitabine is a 2'-deoxyfluorocytidine with geminal fluoro substituents at the 2'-position. It inhibits ribonucleotide reductase and is used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer. Gemcitabine functions as a DNA synthesis inhibitor, prodrug, EC 1.17.4.1 inhibitor, photosensitizing agent, radiosensitizing agent, antineoplastic agent, antimetabolite, antiviral drug, immunosuppressive agent, environmental contaminant, xenobiotic, organofluorine compound, and pyrimidine 2'-deoxyribonucleoside.
| CAS No. | 95058-81-4 |
|---|---|
| Product Name | Gemcitabine |
Biological Targets
POLA1·POLD4·POLD3·POLD1·POLD2·
Associated Conditions
brain cancer·urethral neoplasm·angioimmunoblastic T-cell lymphoma·squamous cell carcinoma·renal cell carcinoma·
* The information provided here is compiled from public sources and is for reference only.
